CMPS COMPASS Pathways Plc - American Depository Shares
$13.61
가격 · 8월 18, 2026
기준 재무 정보 8월 5, 2026
52주 범위
$4–$15
84% of range
애널리스트 평점
BUY
24 analysts
목표 주가
$24
+75% upside
P/E (TTM)
-4.4
ROE
-524.8%
순이익률
—
COMPASS Pathways Plc - American Depository Shares 정보 위키백과 회사 개요
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
더 보기
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.
Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.
Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
CMPS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$13.61
시가총액
$1.31B
P/E (TTM)
-4.4
EPS (TTM)
$-3.08
매출 (TTM)
—
배당 수익률
—
ROE
-524.8%
부채/자본
-0.6
52주 범위
$4 – $15
CMPS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-3.08
2019-12-31
→
2025-12-31
잉여현금흐름
—
2021-12-31
→
2024-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
CMPS
동종업계 중앙값
P/E (TTM)
-4.4
66.9
P/B
-24.7
3.7
EV / EBITDA
-6.6
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
CMPS
동종업계 중앙값
ROA
-135.8%
-23.9%
ROE
-524.8%
-27.7%
ROIC
836.7%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
CMPS
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
-0.6
4.4
Current Ratio (유동비율)
0.8
4.0
Quick Ratio (당좌 비율)
0.6
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
CMPS
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
CMPS
동종업계 중앙값
CMPS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
24 명의 애널리스트
- 적극 매수 8 33.3%
- 매수 14 58.3%
- 보유 2 8.3%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
16 명의 애널리스트 · 2026-08-16
중앙값
$21.00
지금
$13.61
저가
$13.00
고가
$65.00
중앙값 목표
$21.00
+54.3%
평균 목표
$23.75
+74.5%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.27%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-1.88 | $-0.41 | -1.5% |
| 2026년 3월 31일 | $0.71 | $-0.39 | 1.1% |
| 2025년 12월 31일 | $-1.00 | $-0.40 | -0.60% |
| 2025년 9월 30일 | $-1.44 | $-0.40 | -1.0% |
| 2025년 6월 30일 | $-0.41 | $-0.44 | 0.03% |
| 2025년 3월 31일 | $-0.38 | $-0.48 | 0.10% |
| 2024년 12월 31일 | $-0.63 | $-0.64 | 0.01% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
| BDRX | — | — | — | — | — | — |
| KNSA | $3.15B | 55.0 | 60.1% | 8.7% | 11.1% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $118M | $119M | $88M | $65M | $44M | $23M | |
| SG&A Expense | $61M | $59M | $49M | $45M | $39M | $28M | |
| Operating Expenses | $179M | $178M | $137M | $110M | $83M | $51M | |
| Operating Income | $-179M | $-178M | $-137M | $-110M | $-83M | $-51M | |
| Interest Expense | · | · | $2M | $0 | $0 | · | |
| Interest Income | $7M | $8M | $5M | · | · | · | |
| Other Non-op | $1M | $823.0K | $255.0K | $19M | $12M | $-9M | |
| Pretax Income | $-290M | $-154M | $-118M | $-91M | $-72M | $-60M | |
| Income Tax | $-2M | $2M | $780.0K | $408.0K | $199.0K | $32.0K | |
| Net Income | $-288M | $-155M | $-118M | $-92M | $-72M | $-60M | |
| EPS (Basic) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| EPS (Diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| Shares (Basic) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| Shares (Diluted) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| EBITDA | $-179M | $-178M | $-137M | $-110M | $-83M | · |
대차대조표 22
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $165M | $220M | $143M | $273M | $190M | |
| Prepaid Expense | $42M | $36M | $41M | $48M | $22M | $12M | |
| Other Current Assets | $6M | $4M | $2M | $1M | $1M | $509.0K | |
| Current Assets | $191M | $201M | $261M | $192M | $295M | $202M | |
| PP&E (Net) | · | $189.0K | $423.0K | $617.0K | $398.0K | $245.0K | |
| PP&E (Gross) | · | · | · | $1M | $756.0K | $433.0K | |
| Accum. Depreciation | · | · | · | $530.0K | $358.0K | $188.0K | |
| Other Non-current Assets | $12M | $7M | $7M | $1M | $213.0K | $57.0K | |
| Total Assets | $210M | $214M | $276M | $197M | $301M | $203M | |
| Accounts Payable | $15M | $12M | $6M | $5M | $3M | $3M | |
| Current Liabilities | $248M | $34M | $20M | $16M | $15M | $7M | |
| Capital Leases | $1M | $303.0K | $2M | $418.0K | $1M | · | |
| Total Liabilities | $263M | $59M | $50M | $16M | $16M | $7M | |
| Long-term Debt | $32M | $30M | $29M | $0 | · | · | |
| Total Debt | $32M | $30M | · | · | · | · | |
| Common Stock | $973.0K | $702.0K | $635.0K | · | · | · | |
| Paid-in Capital | $784M | $705M | $622M | $459M | $445M | $279M | |
| Retained Earnings | $-823M | $-535M | $-380M | $-261M | $-170M | $-98M | |
| AOCI | $-15M | $-16M | $-17M | $-17M | $9M | $15M | |
| Stockholders' Equity | $-53M | $155M | $226M | $181M | $284M | $197M | |
| Liabilities + Equity | $210M | $214M | $276M | $197M | $301M | $203M | |
| Shares Outstanding | 96,085,785 | 68,552,215 | 61,943,471 | · | · | · |
현금 흐름 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | $242.0K | $330.0K | $175.0K | $112.0K | |
| Stock-based Comp | $14M | $20M | $17M | $13M | $9M | $18M | |
| Deferred Tax | $22.0K | $-437.0K | $-1M | $-1M | $-545.0K | $-221.0K | |
| Other Non-cash | · | · | $5M | $-26M | $-4M | · | |
| Operating Cash Flow | $-157M | $-119M | $-97M | $-105M | $-68M | $-41M | |
| CapEx | · | $0 | $66.0K | $596.0K | $334.0K | $131.0K | |
| Investing Cash Flow | · | $0 | $-64.0K | $-596.0K | $-334.0K | $-628.0K | |
| Debt Issued | · | $0 | $30M | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $30M | · | · | · | |
| Stock Issued | $140M | $26M | $145M | $440.0K | $155M | $0 | |
| Net Stock Activity | $140M | $26M | $145M | $440.0K | $155M | · | |
| Financing Cash Flow | $141M | $64M | $174M | $1M | $157M | $194M | |
| Net Change in Cash | $-15M | $-55M | $77M | $-130M | $83M | $165M | |
| Taxes Paid | $755.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-119M | $-97M | $-106M | $-68M | · | |
| Levered FCF | · | · | $-100M | · | · | · |
수익성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | · | |
| ROE | -524.8% | -89.2% | -49.5% | -48.7% | -24.3% | · | |
| ROIC | 836.7% | -97.4% | -61.1% | -61.2% | -29.3% | · |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 | · | |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 | · | |
| Debt / Equity | -0.6 | 0.2 | · | · | · | · | |
| LT Debt / Equity | -0.3 | 0.2 | · | · | · | · | |
| Interest Coverage | · | · | -62.1 | · | · | · |
가치 평가 (TTM) 11
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-288M | $-155M | $-118M | $-92M | $-72M | · | |
| Market Cap | $663M | $259M | · | · | · | · | |
| Enterprise Value | $545M | $124M | · | · | · | · | |
| P/E | -2.2 | -1.6 | -3.8 | -3.7 | -12.3 | · | |
| P/B | -12.5 | 1.7 | · | · | · | · | |
| P / Tangible Book | · | 1.7 | · | · | · | · | |
| P / Cash Flow | -4.2 | -2.2 | · | · | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | |
| EV / EBITDA | -3.0 | -0.7 | · | · | · | · | |
| EV / FCF | · | -1.0 | · | · | · | · | |
| Earnings Yield | -44.6% | -60.9% | -26.5% | -26.9% | -8.1% | · |
손익계산서 15
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $26M | $30M | $27M | $30M | $31M | $32M | $33M | $29M | $25M | $27M | $22M | $20M | $19M | $20M | $14M | |
| SG&A Expense | $23M | $16M | $16M | $13M | $13M | $19M | $16M | $15M | $14M | $14M | $11M | $13M | $13M | $13M | $12M | $12M | |
| Operating Expenses | $52M | $43M | $46M | $41M | $43M | $50M | $48M | $48M | $43M | $39M | $38M | $34M | $33M | $32M | $32M | $26M | |
| Operating Income | $-52M | $-43M | $-46M | $-41M | $-43M | $-50M | $-48M | $-48M | $-43M | $-39M | $-38M | $-34M | $-33M | $-32M | $-32M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | · | $0 | $0 | $0 | |
| Interest Income | $4M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $638.0K | · | · | · | |
| Other Non-op | $546.0K | $484.0K | $370.0K | $383.0K | $-176.0K | $803.0K | $337.0K | $191.0K | $167.0K | $128.0K | $-8M | $112.0K | $-11.0K | $8M | $1M | $7M | |
| Pretax Income | $-253M | $91M | $-97M | $-138M | $-38M | $-18M | $-42M | $-38M | $-38M | $-35M | $-32M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| Income Tax | $331.0K | $-11.0K | $-3M | $-230.0K | $137.0K | $354.0K | $1M | $173.0K | $176.0K | $222.0K | $394.0K | $62.0K | $194.0K | $130.0K | $92.0K | $120.0K | |
| Net Income | $-254M | $91M | $-94M | $-138M | $-38M | $-18M | $-43M | $-39M | $-38M | $-35M | $-33M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| EPS (Basic) | $-1.88 | $0.71 | $-1.03 | $-1.44 | $-0.41 | $-0.20 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| EPS (Diluted) | $-1.88 | $-0.30 | $-0.99 | $-1.44 | $-0.41 | $-0.24 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| Shares (Basic) | 135,039,810 | 110,064,581 | -184,367,003 | 95,337,993 | 93,341,594 | 89,192,252 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| Shares (Diluted) | 135,039,810 | 130,266,693 | -193,816,374 | 95,337,993 | 93,341,594 | 98,641,623 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| EBITDA | $-52M | $-43M | · | $-41M | $-43M | $-50M | · | $-48M | $-43M | $-39M | · | $-34M | $-33M | $-32M | · | $-25M |
대차대조표 22
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $433M | $466M | $150M | $186M | $222M | $260M | $165M | $207M | $229M | $263M | $220M | $248M | $148M | $117M | $143M | $173M | |
| Prepaid Expense | $42M | $44M | $42M | $56M | $54M | $45M | $36M | $26M | $36M | $31M | $41M | $36M | $45M | $50M | $48M | $45M | |
| Other Current Assets | $8M | $7M | $6M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $476M | $511M | $191M | $242M | $276M | $305M | $201M | $234M | $265M | $296M | $261M | $285M | $194M | $168M | $192M | $218M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $359.0K | $423.0K | $309.0K | $482.0K | $612.0K | $617.0K | $555.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $395.0K | |
| Other Non-current Assets | $20M | $14M | $12M | $5M | $9M | $8M | $7M | $7M | $6M | $6M | $7M | $6M | $7M | $212.0K | $1M | $299.0K | |
| Total Assets | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Accounts Payable | $12M | $11M | $15M | $5M | $11M | $9M | $12M | $8M | $8M | $9M | $6M | $4M | $2M | $4M | $5M | $20M | |
| Current Liabilities | $367M | $154M | $248M | $197M | $31M | $30M | $34M | $26M | $22M | $19M | $20M | $15M | $13M | $11M | $16M | $30M | |
| Capital Leases | $2M | $779.0K | $1M | $2M | $2M | $259.0K | $303.0K | $459.0K | $799.0K | $1M | $2M | $2M | $3M | $412.0K | $418.0K | $425.0K | |
| Total Liabilities | $420M | $205M | $263M | $218M | $131M | $124M | $59M | $54M | $52M | $50M | $50M | $46M | $43M | $12M | $16M | $30M | |
| Long-term Debt | $51M | $50M | $32M | $31M | $31M | $31M | $30M | $30M | $29M | $29M | $29M | $28M | $28M | · | $0 | · | |
| Total Debt | $51M | $50M | · | $31M | $31M | $31M | · | $28M | · | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $973.0K | $973.0K | $946.0K | $938.0K | $702.0K | $699.0K | $699.0K | $699.0K | $635.0K | · | · | · | · | · | |
| Paid-in Capital | $1.08B | $1.07B | $784M | $781M | $767M | $763M | $705M | $700M | $695M | $690M | $622M | $617M | $496M | $464M | $459M | $455M | |
| Retained Earnings | $-985M | $-731M | $-823M | $-729M | $-591M | $-553M | $-535M | $-491M | $-453M | $-415M | $-380M | $-347M | $-314M | $-285M | $-261M | $-230M | |
| AOCI | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-31M | |
| Stockholders' Equity | $85M | $327M | $-53M | $38M | $163M | $195M | $155M | $193M | $226M | $259M | $226M | $253M | $166M | $162M | $181M | $195M | |
| Liabilities + Equity | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Shares Outstanding | 135,722,306 | 134,923,295 | 96,085,785 | 96,002,044 | 93,586,348 | 92,848,326 | 68,552,215 | 68,409,068 | 68,387,469 | 68,342,534 | 61,943,471 | · | · | · | · | · |
현금 흐름 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $59.0K | $63.0K | $61.0K | · | $186.0K | $110.0K | $48.0K | $76.0K | $100.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $9M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-40M | $-48M | $-38M | $-35M | $-39M | $-46M | $-42M | $-22M | $-34M | $-21M | $-28M | $-17M | $-25M | $-28M | $-45M | $-19M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $18.0K | $19.0K | $29.0K | $107.0K | $-5.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-18.0K | $-17.0K | $-29.0K | $-107.0K | $5.0K | |
| Debt Issued | $0 | $19M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Debt Issued | · | $19M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $141M | $0 | $0 | $0 | $140M | $0 | $0 | $0 | $26M | $-41.0K | $117M | $27M | $1M | $440.0K | $0 | |
| Net Stock Activity | · | $141M | · | · | · | $140M | · | · | · | $26M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $8M | $362M | $187.0K | $0 | $166.0K | $140M | $155.0K | $-53.0K | $210.0K | $64M | $41.0K | $117M | $56M | $1M | $639.0K | $-1.0K | |
| Net Change in Cash | $-33M | $316M | $-36M | $-36M | $-38M | $95M | $-42M | $-22M | $-34M | $43M | $-28M | $100M | $31M | $-26M | $-30M | $-34M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M | · | · | · | $-28M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-22M | · | · | · | · | · | · |
수익성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.6% | 21.4% | · | -54.8% | -13.4% | -5.7% | · | -14.1% | -15.6% | -14.6% | · | -12.8% | -12.6% | -10.9% | · | -16.4% | |
| ROE | -205.4% | 34.9% | · | -119.4% | -19.8% | -7.9% | · | -17.2% | -19.4% | -16.7% | · | -14.9% | -14.5% | -11.5% | · | -18.9% | |
| ROIC | -38.8% | -11.4% | · | -58.8% | -22.3% | -22.4% | · | -21.8% | -19.2% | -15.0% | · | -13.5% | -19.8% | -19.8% | · | -13.2% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 3.3 | · | 1.2 | 8.8 | 10.2 | · | 8.9 | 12.0 | 15.2 | · | 18.6 | 15.2 | 14.9 | · | 7.4 | |
| Quick Ratio | 1.2 | 3.0 | · | 0.9 | 7.1 | 8.7 | · | 7.9 | 10.4 | 13.5 | · | 16.2 | 11.6 | 10.4 | · | 5.9 | |
| Debt / Equity | 0.6 | 0.2 | · | 0.8 | 0.2 | 0.2 | · | 0.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.2 | · | 0.5 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.1 | · | -31.5 | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-339M | $-103M | · | $-232M | $-133M | $-130M | · | $-145M | $-135M | $-121M | · | $-104M | $-92M | $-85M | · | $-76M | |
| Market Cap | $1.92B | $746M | · | $550M | $262M | $266M | · | $431M | $413M | $569M | · | · | · | · | · | · | |
| Enterprise Value | $1.54B | $331M | · | $395M | $71M | $36M | · | $252M | · | · | · | · | · | · | · | · | |
| P/E | -3.5 | -2.3 | · | -2.2 | -1.6 | -1.5 | · | -2.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -5.0 | · | -5.9 | |
| P/B | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Cash Flow | · | -15.6 | · | · | · | -5.8 | · | · | · | -27.3 | · | · | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -27.3 | · | · | · | · | · | · | |
| EV / EBITDA | -29.4 | -7.7 | · | -9.8 | -1.7 | -0.7 | · | -5.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -28.5% | -43.2% | · | -46.2% | -63.2% | -66.8% | · | -37.1% | -10294.4% | -7473.4% | · | -8401.0% | -7506.0% | -20.1% | · | -16.9% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-288M | $-155M | $-118M | $-92M | $-72M |
| 희석 EPS | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | -0.6 | 0.2 | — | — | — |
| 유동비율 | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 |
| 당좌 비율 | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | — | $-119M | $-97M | $-106M | $-68M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 250개의 제출자 · $1.3B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 66 (+6 이전 분기 대비) | 30 (+7 이전 분기 대비) | 77 (+3 이전 분기 대비) | 53 (+26 이전 분기 대비) | -2.0M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Deep Track Capital, LP | $172,085,168 | 12,161,496 | 13.73% | 주식 |
| RTW INVESTMENTS, LP | $151,418,782 | 10,700,974 | 12.08% | 주식 |
| BIT Capital GmbH | $89,835,478 | 6,348,797 | 7.17% | 주식 |
| TANG CAPITAL MANAGEMENT LLC | $70,750,000 | 5,000,000 | 5.65% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $63,257,363 | 4,470,485 | 5.05% | 주식 |
| ARK Investment Management LLC | $48,845,310 | 3,451,965 | 3.90% | 주식 |
| Point72 Asset Management, L.P. | $37,085,424 | 2,620,878 | 2.96% | 주식 |
| Logos Global Management LP | $31,837,500 | 2,250,000 | 2.54% | 주식 |
| Eagle Health Investments LP | $29,155,042 | 2,060,427 | 2.33% | 주식 |
| DAFNA Capital Management LLC | $28,469,121 | 2,011,952 | 2.27% | 주식 |
| BANK OF AMERICA CORP /DE/ | $28,339,691 | 2,002,805 | 2.26% | 주식 |
| Caption Management, LLC | $27,544,390 | 1,946,600 | 2.20% | 콜 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $26,855,285 | 1,897,900 | 2.14% | 콜 옵션 |
| NEXTBio Capital Management LP | $25,126,990 | 1,775,759 | 2.00% | 주식 |
| MARSHALL WACE, LLP | $20,935,350 | 1,479,530 | 1.67% | 주식 |
| Aisling Capital Management LP | $20,267,554 | 1,432,336 | 1.62% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $20,261,229 | 1,431,889 | 1.62% | 주식 |
| Candriam S.C.A. | $18,013,686 | 1,274,278 | 1.44% | 주식 |
| Woodline Partners LP | $15,366,957 | 1,086,004 | 1.23% | 주식 |
| Jefferies Financial Group Inc. | $14,070,661 | 994,393 | 1.12% | 주식 |
| Trexquant Investment LP | $12,171,236 | 860,158 | 0.97% | 주식 |
| Kalehua Capital Management LLC | $11,598,642 | 819,692 | 0.93% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $10,909,466 | 770,987 | 0.87% | 주식 |
| Caption Management, LLC | $10,699,041 | 756,116 | 0.85% | 주식 |
| Eversept Partners, LP | $9,520,474 | 672,825 | 0.76% | 주식 |
| Propel Bio Management, LLC | $8,109,167 | 573,086 | 0.65% | 주식 |
| Creek Drive Management Group LLC | $8,093,800 | 572,000 | 0.65% | 주식 |
| Occam Crest Management LP | $7,739,000 | 710,000 | 0.62% | 주식 |
| CITADEL ADVISORS LLC | $7,567,420 | 534,800 | 0.60% | 콜 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7,140,090 | 504,600 | 0.57% | 풋 옵션 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $7,122,855 | 503,382 | 0.57% | 주식 |
| JANE STREET GROUP, LLC | $7,075,821 | 500,058 | 0.56% | 주식 |
| Qube Research & Technologies Ltd | $7,070,415 | 499,676 | 0.56% | 주식 |
| Walleye Capital LLC | $6,893,385 | 487,165 | 0.55% | 주식 |
| Ensign Peak Advisors, Inc | $6,716,340 | 474,653 | 0.54% | 주식 |
| Blue Owl Capital Holdings LP | $6,367,500 | 450,000 | 0.51% | 주식 |
| AdvisorShares Investments LLC | $5,962,060 | 421,347 | 0.48% | 주식 |
| CITADEL ADVISORS LLC | $5,952,679 | 420,684 | 0.47% | 주식 |
| TWO SIGMA ADVISERS, LP | $5,909,850 | 856,500 | 0.47% | 주식 |
| GOLDMAN SACHS GROUP INC | $5,540,956 | 391,587 | 0.44% | 주식 |
| HighVista Strategies LLC | $5,251,349 | 371,120 | 0.42% | 주식 |
| Legal & General Group Plc | $4,700,154 | 332,206 | 0.38% | 주식 |
| Sumitomo Mitsui Trust Group, Inc. | $4,573,407 | 323,209 | 0.36% | 주식 |
| Amova Asset Management Americas, Inc. | $4,517,334 | 319,472 | 0.36% | 주식 |
| Squadron Capital Management LLC | $4,315,750 | 305,000 | 0.34% | 콜 옵션 |
| Affinity Asset Advisors, LLC | $4,261,739 | 301,183 | 0.34% | 주식 |
| SEVEN GRAND MANAGERS, LLC | $4,245,000 | 300,000 | 0.34% | 주식 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4,245,000 | 300,000 | 0.34% | 주식 |
| Squadron Capital Management LLC | $4,245,000 | 300,000 | 0.34% | 주식 |
| AMERIPRISE FINANCIAL INC | $4,081,271 | 288,429 | 0.33% | 주식 |
| JANE STREET GROUP, LLC | $4,079,445 | 288,300 | 0.33% | 콜 옵션 |
| STEMPOINT CAPITAL LP | $4,029,481 | 284,769 | 0.32% | 주식 |
| TORONTO DOMINION BANK | $3,930,233 | 277,755 | 0.31% | 주식 |
| ROYCE & ASSOCIATES LP | $3,778,885 | 267,059 | 0.30% | 주식 |
| PFM Health Sciences, LP | $3,503,384 | 247,589 | 0.28% | 주식 |
| D. E. Shaw & Co., Inc. | $3,408,367 | 240,874 | 0.27% | 주식 |
| Brown University | $3,030,930 | 214,200 | 0.24% | 주식 |
| MORGAN STANLEY | $2,973,693 | 210,155 | 0.24% | 주식 |
| Caption Management, LLC | $2,950,275 | 208,500 | 0.24% | 풋 옵션 |
| HEIGHTS CAPITAL MANAGEMENT, INC | $2,913,938 | 205,932 | 0.23% | 주식 |
| CITADEL ADVISORS LLC | $2,695,575 | 190,500 | 0.22% | 풋 옵션 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2,481,528 | 175,373 | 0.20% | 주식 |
| Engineers Gate Manager LP | $2,432,343 | 171,897 | 0.19% | 주식 |
| Y-Intercept (Hong Kong) Ltd | $2,378,474 | 168,090 | 0.19% | 주식 |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $2,122,500 | 150,000 | 0.17% | 주식 |
| Squarepoint Ops LLC | $1,962,195 | 138,671 | 0.16% | 주식 |
| Balyasny Asset Management L.P. | $1,959,492 | 138,480 | 0.16% | 주식 |
| ALPS ADVISORS INC | $1,930,937 | 136,462 | 0.15% | 주식 |
| Founders Fund VII Management, LLC | $1,924,272 | 278,880 | 0.15% | 주식 |
| K2 PRINCIPAL FUND, L.P. | $1,911,665 | 135,100 | 0.15% | 주식 |
| WELLS FARGO & COMPANY/MN | $1,897,246 | 134,081 | 0.15% | 주식 |
| CenterBook Partners LP | $1,777,155 | 125,594 | 0.14% | 주식 |
| Creek Drive Management Group LLC | $1,698,000 | 120,000 | 0.14% | 콜 옵션 |
| BANK OF MONTREAL /CAN/ | $1,686,991 | 119,222 | 0.13% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $1,639,118 | 115,839 | 0.13% | 주식 |
| Palo Alto Investors LP | $1,635,966 | 115,616 | 0.13% | 주식 |
| Simplify Asset Management Inc. | $1,617,076 | 114,281 | 0.13% | 주식 |
| LPL Financial LLC | $1,550,387 | 109,568 | 0.12% | 주식 |
| GROUP ONE TRADING LLC | $1,390,917 | 98,298 | 0.11% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $1,341,448 | 94,802 | 0.11% | 주식 |
| CreativeOne Wealth, LLC | $1,336,312 | 94,439 | 0.11% | 주식 |
| STABLEFORD CAPITAL II LLC | $1,300,003 | 91,873 | 0.10% | 주식 |
| STATE STREET CORP | $1,150,098 | 81,279 | 0.09% | 주식 |
| Lion Point Capital, LP | $1,132,000 | 80,000 | 0.09% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $1,063,896 | 75,187 | 0.08% | 주식 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $1,016,635 | 71,847 | 0.08% | 주식 |
| DLD Asset Management, LP | $990,500 | 70,000 | 0.08% | 풋 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $941,852 | 66,562 | 0.08% | 주식 |
| Aquatic Capital Management LLC | $922,297 | 65,180 | 0.07% | 주식 |
| JANE STREET GROUP, LLC | $915,505 | 64,700 | 0.07% | 풋 옵션 |
| Dorsey Wright & Associates | $883,653 | 62,449 | 0.07% | 주식 |
| Campbell & CO Investment Adviser LLC | $874,696 | 61,816 | 0.07% | 주식 |
| STIFEL FINANCIAL CORP | $855,639 | 60,469 | 0.07% | 주식 |
| Intellectus Partners, LLC | $841,925 | 59,500 | 0.07% | 주식 |
| DCF Advisers, LLC | $767,638 | 54,250 | 0.06% | 주식 |
| CIBC WORLD MARKET INC. | $737,357 | 52,110 | 0.06% | 주식 |
| NATIONAL BANK OF CANADA /FI/ | $731,420 | 51,727 | 0.06% | 주식 |
| FLAX POND CAPITAL, LLC | $728,951 | 51,516 | 0.06% | 주식 |
| EXCHANGE TRADED CONCEPTS, LLC | $708,943 | 50,102 | 0.06% | 주식 |
| PEAK6 LLC | $707,500 | 50,000 | 0.06% | 콜 옵션 |
회사 내부자 9 명의 내부자 · 0 임원 · 0 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Kabir Nath | — | 2026년 8월 3일 F | 361,028 | 0 | 0 | $0 |
| Robert Mcquade | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
| Daphne Karydas | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
| Justin D. Gover | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
| David Y Norton | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
| Wayne Joseph Riley | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
| Gino Santini | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
| Jeffrey M Jonas | — | 2026년 5월 27일 A | — | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| AtaiBeckley Inc. | 2026년 2월 17일 | 4.96% | 수정본 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 6 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2.43% | 3,316,076 NS | 2026년 4월 30일 | N-PORT |
| BBC · ETFis Series Trust I | 0.99% | 40,950 NS | 2026년 4월 30일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.12% | 7,246 SH | 2026년 8월 8일 | 일간 |
| IBB · iShares Trust | 0.11% | 797,974 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.06% | 3,487 NS | 2026년 5월 31일 | N-PORT |
| APIE · Trust for Professional Managers | 0.03% | 21,455 NS | 2026년 5월 31일 | N-PORT |